La NFID anuncia la Junta Directiva 2026-2027

Bethesda, MD (July 8, 2026)—The National Foundation for Infectious Diseases (NFID) is pleased to announce the 2026-2027 NFID Board of Directors and leadership team, including President Monica M. Farley, MD; President-Elect Kevin A. Ault, MD; Vice President Ruth Lynfield, MD; Immediate Past-President Jeffery A. Goad, PharmD, MPH; and Secretary-Treasurer Kevin M. Rooney. Oliver T. Brooks, MD, of Charles R. Drew University of Medicine and Science, and Flor M. Muñoz, MD, MSc, of Baylor College of Medicine, were reappointed for 3-year terms through June 2029.

Monica M. Farley, MD, emerita professor of medicine and former director of the Division of Infectious Diseases at Emory University School of Medicine, officially began her term as NFID president on July 1, 2026. A nationally recognized expert on invasive bacterial infections, foodborne pathogens, and vaccine-preventable diseases, she previously served as NFID president-elect. Her areas of expertise include pneumococcal disease, Haemophilus influenzae disease, Group B Streptococcal infections, Clostridioides difficile infections, and community-associated methicillin-resistant Staphylococcus aureus (MRSA) disease.

"Public health currently faces significant challenges, but these challenges also present an opportunity to strengthen partnerships and reaffirm our shared commitment to protecting people from infectious diseases," Farley said. "As NFID president, I look forward to working alongside an exceptional Board of Directors and partners across the country to advance evidence-based education, elevate trusted voices, and ensure that science continues to guide decisions that improve health for all."

Kevin A. Ault, MD, a board-certified obstetrician-gynecologist, will serve as president-elect. A recognized leader in maternal immunization and vaccine policy, he previously served as a voting member of the Advisory Committee on Immunization Practices (ACIP), which advises the US Centers for Disease Control and Prevention (CDC).

Ruth Lynfield, MD, an adjunct professor in medicine and in epidemiology at the University of Minnesota, assumes the role of vice president. A pediatric infectious diseases physician and public health leader, she has conducted research on emerging infectious diseases, investigated outbreaks, and helped develop public health policy on the prevention and control of infectious diseases. She serves on the Executive Steering Committee of the Measles Collaborative, an NFID-led initiative that aims to strengthen measles prevention, response, and education nationwide. Lynfield previously served as president of the Council of State and Territorial Epidemiologists and works at the Minnesota Department of Health. Es miembro de la Junta Directiva de la NFID a título personal.

Jeffery A. Goad, PharmD, MPH, professor of pharmacy practice at Chapman University School of Pharmacy, transitions to immediate past-president after serving as the first pharmacist to lead NFID as president. During his tenure, he championed multidisciplinary collaboration and strengthened efforts to build public confidence in vaccines and other evidence-based strategies to prevent infectious diseases.

Kevin Rooney continues to serve as secretary-treasurer, providing strategic financial oversight and governance leadership for the organization. He is president of Beacon Consulting Group, a commercial strategy consultancy providing advisory services for biopharma firms.

NFID also welcomes 3 new members to its Board of Directors:

William P. Hausdorff, PhD, lead for meningococcal vaccine development and vaccine value propositions at PATH, has dedicated his career to expanding access to lifesaving vaccines around the world. Following doctoral and postdoctoral training at Johns Hopkins University, the National Institutes of Health, and Duke University, he held leadership roles at the US Agency for International Development (USAID), the CDC, and two global vaccine manufacturers before joining PATH. También ha contribuido a los programas educativos de la NFID como orador y asesor.

Veronica V. McNally, JD, president of the Franny Strong Foundation and director of Trial Advocacy and Externships at Michigan State University College of Law, is a prominent vaccine advocate and public health leader. Fundó la campaña I Vaccinate con el Departamento de Salud y Servicios Humanos de Michigan para ayudar a los padres a tomar decisiones informadas sobre las vacunas. She previously served as the consumer representative on ACIP and as an attorney advisor to the Health Resources and Services Administration (HRSA) Advisory Commission on Childhood Vaccines. She currently serves on the Michigan Advisory Committee on Immunizations and Michigan’s Building a Sustainable Immunization Coalition.

Jessica (Jess) Steier, DrPH, MPH, founder and CEO of Unbiased Science, is a public health scientist and nationally recognized science communicator. Capacitada en ciencias de la evaluación, ha trabajado con departamentos de salud, sistemas de atención médica y agencias federales para evaluar programas y políticas de salud pública. Durante la pandemia de COVID-19, fundó Unskewed Science en respuesta a la creciente necesidad de una comunicación científica clara y basada en la evidencia. También es cofundadora de The Evidence Collective, se desempeña como directora ejecutiva del Centro para la Ciencia y la Salud Imparciales y es escritora colaboradora del Centro de Investigación y Política de Enfermedades Infecciosas (CIDRAP). Se enorgullece de su enfoque empático y humano de la comunicación científica, con el objetivo de tender puentes con quienes más lo necesitan.

The NFID Board of Directors establishes the strategic direction for the organization, ensures that annual goals are met, and provides financial oversight to support NFID’s mission of educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan.

"We are delighted to welcome Monica Farley as NFID president and William Hausdorff, Veronica McNally, and Jessica Steier to the NFID Board of Directors," said Rebecca Alvania, PhD, MA, MPH, chief executive officer of NFID. "Their expertise complements the exceptional scientific and clinical leadership already on our Board while bringing additional strengths in vaccine development, science communication, and public engagement that will help guide NFID's work in a rapidly changing public health landscape."

Alvania also recognized and thanked outgoing Board member Julie Morita, MD, and Past President Patricia (Patsy) A. Stinchfield, MS, PNP, for their dedicated service and longstanding commitment to advancing infectious disease prevention and public health. Stinchfield continues to serve NFID as executive director of the Measles Collaborative. Morita serves as president and CEO of the Joyce Foundation.

Junta Directiva de la NFID 2026-2027

• Kevin A. Ault, MD (President-Elect), Obstetrician-Gynecologist
• Oliver T. Brooks, MD, Charles R. Drew University of Medicine and Science
• Wilbur H. Chen, MD, MS, University of Maryland School of Medicine
• Monica M. Farley, MD (President), Emory University School of Medicine
• Jeffery A. Goad, PharmD, MPH (Immediate Past-President), Chapman University School of Pharmacy
• Jean-Venable R. Goode, PharmD, Virginia Commonwealth University
• William P. Hausdorff, PhD, PATH
• Orin S. Levine, PhD, Washington Research Foundation
• Ruth Lynfield, MD (Vice President), University of Minnesota
• Veronica V. McNally, JD, Franny Strong Foundation
• Flor M. Muñoz, MD, MSc, Baylor College of Medicine
• Sean T. O’Leary, MD, MPH, University of Colorado Denver Anschutz Medical Campus
• Kevin M. Rooney (Secretary-Treasurer), Beacon Consulting Group
• Jessica Steier, DrPH, MPH, Unbiased Science
• Audrey M. Stevenson, PhD, MPH, FNP-BC, University of Utah School of Medicine
• Matthew M. Zahn, MD, Rady Children’s Health

Miembros ex oficio:

• Rebecca Alvania, PhD, MA, MPH, NFID CEO
• Robert H. Hopkins, Jr., MD, NFID Medical Director

Acerca de la National Foundation for Infectious Diseases

Fundada en 1973, National Foundation for Infectious Diseases (NFID) es una organización sin fines de lucro 501(c)(3) dedicada a educar e involucrar al público, las comunidades y los profesionales de la salud sobre las enfermedades infecciosas a lo largo de toda la vida. La NFID tiene una calificación de 4 estrellas de Charity Navigator y ha obtenido un sello platino de transparencia de Candid/GuideStar. Para obtener más información, visite www.nfid.org.

Contacto: Diana Olson, dolson@nfid.org